Pakistan Drug Industry Moves To Hike Prices By 18% As Talks Fail
This article was originally published in PharmAsia News
Executive Summary
Drug makers operating in Pakistan have decided to increase their prices by as much as 18% immediately, a response to the failure to reach a long-delayed agreement with the government over a pricing policy.